ClinicalTrials.gg
Not yet recruitingNCT07521072Updated Apr 9, 2026

Testing an Intervention for College Students With Food Insecurity and Binge Eating

An Early Phase 1 interventional study of novel binge eating intervention for college students experiencing food insecurity. in Binge Eating, sponsored by Virginia Polytechnic Institute and State University. Not yet recruiting. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by Virginia Polytechnic Institute and State University · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This study is being conducted to test a new intervention. We are interested in whether it is easy to use and complete and whether you find it helpful in reducing concerns about your eating.

02

Conditions studied

  • Binge Eating

Browse trials for

03

In context

Bulimia

173 studies on the registry are indexed under Bulimia; 33 are open to participants now.

This study's planned enrollment of 10 is below the median of 60 across 143 interventional studies indexed under Bulimia.

Browse Bulimia studies →

Lead sponsor

Virginia Polytechnic Institute and State University is the lead sponsor of 127 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • college student status, ages 18-30 years, current food insecurity, current binge eating, and interest in changing binge eating behaviors. Food security status will be determined by 2-item the Hunger Vital Sign screening, which demonstrates high sensitivity and specificity in identifying individuals with food insecurity; scores must report mild or greater food insecurity to participate. Binge eating and related impairment will be evaluated by the Eating Disorder Diagnostic Scale and the Clinical Impairment Assessment, and the binge eating items from the Eating Disorder Examination interview. Eating behaviors must be consistent with a binge spectrum eating disorder diagnosis, whereby an individual reports binge eating episodes at minimum one time per week for the current month and at least two times per month for the prior two months, to participate. Participants will be permitted to report other mild level symptoms of psychopathology due to the high comorbidity between anxiety, depression, and binge eating among individuals with food insecurity.

Exclusion criteria

Exclusion Criteria:

  • Severe levels of anxiety and depression symptoms.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Binge eating intervention

    This arm will test a novel binge eating intervention for college students experiencing food insecurity.

    Behavioral: novel binge eating intervention for college students experiencing food insecurity.

Interventions

  • Behavioralnovel binge eating intervention for college students experiencing food insecurity.

    this intervention uses aspects of cognitive behavorial therapy for eating disorders combined with compassion-focused therapy techniques.

06

What researchers measure

Primary outcomes

  1. Self-Compassion Scale (SCS)

    SCS is a 26-item survey that measures how an individual perceives themselves, and whether they respond with self-criticism or self-compassion in times of suffering, failure, and perceived inadequacy.

    Time frame: 3 weeks

  2. Experiences of Shame Scale (ESS)

    The ESS is a 25-item survey that assesses an individual's perceived feelings of shame about themselves, their behaviors, and their body weight and shape; higher scores indicate greater feelings of shame.

    Time frame: 3 weeks

  3. Systems Usability Scale (SUS)

    Measures usability of an intervention

    Time frame: 3 weeks

  4. Digital Behavioral Change Interventions (DBCI) Engagement Scale

    Measures intervention engagement

    Time frame: 3 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Dec 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2026
First posted
Apr 9, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
Dec 1, 2027
CompletionEst.
May 1, 2028
Last update
Apr 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07521072
Responsible party
Heather Davis (Assistant Professor, Virginia Polytechnic Institute and State University) — Principal investigator
First posted
Apr 9, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Dec 1, 2027 (estimated)
Completion
May 1, 2028 (estimated)
Last update
Apr 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion